Vosevi Tablet, Film Coated
Product Images NDC 61958-2401

5 FDA label images from Gilead Sciences, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Vosevi (NDC 61958-2401). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gilead Sciences, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Vosevi 01)

Figure (Vosevi 01)
Vosevi tablets packaging with film-coated tablets containing sofosbuvir 400 mg, velpatasvir 100 mg, and voxilaprevir 100 mg. The image shows a full strip of film-coated tablets arranged in a 3x7 grid. The labeler is Gilead Sciences, Inc.*
FDA Label Image

Chemical Structure (Vosevi 02)

Chemical Structure (Vosevi 02)
Chemical structure of the active ingredient Sofosbuvir, as depicted in the image. The diagram shows the molecular framework including key functional groups and stereochemistry.*
FDA Label Image

Chemical Structure (Vosevi 03)

Chemical Structure (Vosevi 03)
Chemical structure of the active ingredients in Vosevi (sofosbuvir, velpatasvir, and voxilaprevir), displayed as a molecular formula diagram with atoms and bonds representing the complex combined structure.*
FDA Label Image

Chemical Structure (Vosevi 04)

Chemical Structure (Vosevi 04)
Chemical structure of the active ingredient in Vosevi, which includes the combined molecular formula for sofosbuvir, velpatasvir, and voxilaprevir, depicted as a detailed structural diagram showing bonds and rings.*
FDA Label Image

Principal Display Panel (28 Tablet Bottle Label)

Principal Display Panel (28 Tablet Bottle Label)
Vosevi tablets packaging label showing the brand name, generic components sofosbuvir, velpatasvir, and voxilaprevir, each tablet containing 400 mg, 100 mg, and 100 mg respectively. The label states a 28-tablet count, oral film-coated tablet form, and includes storage instructions, manufacturer details (Gilead Sciences, Inc.), and a pharmacist alert about medication interactions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.